Drug Side Effects
Search
DEDIFFERENTIATED LIPOSARCOMA
DEDIFFERENTIATED LIPOSARCOMA
was reported 40 times
These drug classes are most commonly taken by patients reporting DEDIFFERENTIATED LIPOSARCOMA:
#
Drug
Count
0
Nucleoside Metabolic Inhibitor [EPC]
10
1
Alkylating Drug [EPC]
6
2
Microtubule Inhibitor [EPC]
5
3
Folate Analog Metabolic Inhibitor [EPC]
4
4
Kinase Inhibitor [EPC]
4
5
Dietary Cholesterol Absorption Inhibitor [EPC]
3
6
HMG-CoA Reductase Inhibitor [EPC]
3
7
Interleukin-6 Receptor Antagonist [EPC]
3
8
beta-Adrenergic Blocker [EPC]
3
9
Corticosteroid [EPC]
2
10
Nonsteroidal Anti-inflammatory Drug [EPC]
2
11
Proteasome Inhibitor [EPC]
2
12
Factor Xa Inhibitor [EPC]
1
13
Fluoroquinolone Antibacterial [EPC]
1
14
Nitroimidazole Antimicrobial [EPC]
1
15
Nuclear Export Inhibitor [EPC]
1
16
SLAMF7-directed Immunostimulatory Antibody [EPC]
1
17
Serotonin-3 Receptor Antagonist [EPC]
1
18
Thalidomide Analog [EPC]
1
19
Tumor Necrosis Factor Blocker [EPC]
1